(R)-5-(2-(5-cyano-2-cyclopropoxyphenylamino)pyrimidin-4-yl)-3-(hydroxymethyl)-3-methylindoline-7-carbonitrile

ID: ALA4212714

PubChem CID: 130271143

Max Phase: Preclinical

Molecular Formula: C25H22N6O2

Molecular Weight: 438.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@]1(CO)CNc2c(C#N)cc(-c3ccnc(Nc4cc(C#N)ccc4OC4CC4)n3)cc21

Standard InChI:  InChI=1S/C25H22N6O2/c1-25(14-32)13-29-23-17(12-27)9-16(10-19(23)25)20-6-7-28-24(30-20)31-21-8-15(11-26)2-5-22(21)33-18-3-4-18/h2,5-10,18,29,32H,3-4,13-14H2,1H3,(H,28,30,31)/t25-/m1/s1

Standard InChI Key:  FUZOISPBFQGDJS-RUZDIDTESA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   13.9748   -4.1974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2690   -4.6101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9793   -5.0150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2453   -5.1673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2441   -5.9868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9522   -6.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6618   -5.9863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9539   -7.2108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2444   -7.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2439   -8.4350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9520   -8.8446    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6622   -8.4318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6592   -7.6167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9504   -4.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6624   -5.1650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9322   -3.8659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1172   -3.9556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5375   -4.7588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8269   -4.3501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9702   -3.3802    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3712   -8.8381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0776   -8.4271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7834   -8.8343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4893   -8.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4870   -7.6060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7730   -7.1999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0700   -7.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7674   -6.3827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7631   -5.5635    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7847   -9.6515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4931  -10.0589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9016  -10.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3091  -10.0537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  1
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7 15  1  0
 14  4  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  6  8  1  0
 14 15  2  0
 15  2  1  0
  2 16  1  0
 16 17  1  0
 17 14  1  0
  4 18  1  0
 18 19  3  0
  1 20  1  0
 12 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 26 28  1  0
 28 29  3  0
 23 30  1  0
 30 31  1  0
 32 31  1  0
 33 32  1  0
 31 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4212714

    ---

Associated Targets(Human)

JJN-3 (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KMS-12-BM (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP3K14 Tchem Mitogen-activated protein kinase kinase kinase 14 (1412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.49Molecular Weight (Monoisotopic): 438.1804AlogP: 3.85#Rotatable Bonds: 6
Polar Surface Area: 126.88Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.56CX Basic pKa: 2.09CX LogP: 3.20CX LogD: 3.20
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.53Np Likeness Score: -0.45

References

1. Kargbo RB..  (2017)  New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders.,  (9): [PMID:28947934] [10.1021/acsmedchemlett.7b00330]

Source